Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Velcade in AL-Amyloidosis
NCT00298766Phase 2Completed
- Sponsor
- Millennium Pharmaceuticals
- Start
- Jun 2005
- Primary completion
- Jul 2009
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of bortezomib in systemic light chain amyloidosis, sponsored by Millennium Pharmaceuticals. Started Jun 2005; status: completed.
02
Drugs
bortezomib
03
Conditions
systemic light chain amyloidosis
Beyond the preview
Go deeper on NCT00298766.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00298766.